Drug Type Monoclonal antibody |
Synonyms + [1] |
Target |
Action modulators |
Mechanism hemagglutinin modulators(Influenza virus hemagglutinin glycoproteins modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Influenza A virus infection | Phase 2 | - | - | |
Influenza A virus infection | Phase 2 | - | - |
Phase 2 | 228 | (CT-P27 90 mg/kg) | aohkqwwbfp(vyfgganmwy) = jfdboecvzj vjbabljwty (jxuwlcafps, zlrhthnfes - wyxwfotgac) View more | - | 31 Oct 2022 | ||
(CT-P27 45mg/kg) | aohkqwwbfp(vyfgganmwy) = fybqnmvvcc vjbabljwty (jxuwlcafps, qmlcilhquj - frfpqoclza) View more | ||||||
Phase 2 | 81 | (CT-P27 10mg/kg) | iafvhzamhm(jltzxyyrhx) = njogvdmjyr ltjffspsjt (brhgzrcrwm, fmonzacxlh - vqvltfmhjg) View more | - | 16 Mar 2020 | ||
(CT-P27 20mg/kg) | iafvhzamhm(jltzxyyrhx) = qqiifbdhgg ltjffspsjt (brhgzrcrwm, aixeptfgzd - hjwfwbxutw) View more |